T1	Participants 1100 1234	94 women was 51 years (range 27-76): 79 received fluorouracil/epirubicin/cyclophosphamide and 15 received doxorubicin/cyclophosphamide
T2	Participants 808 854	chemotherapy-naïve patients with breast cancer
